Roivant Sciences
ROIV · NASDAQ
Bulios Fair Price
$27.45
33.1% downside
Trenutna cena
$41.01
Po podatkih Bulios Fair Price je delnica ROIV trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Roivant Sciences (ROIV) is a biotechnology company specializing in the development and commercialization of innovative drugs and therapies. Utilizing advanced technologies and a strategic approach to research and development, Roivant Sciences focuses on rapidly bringing new treatment options to market. The company is known for its unique model and portfolio, which includes various therapeutic areas. Roivant Sciences is also engaged in partnerships with other organizations to accelerate healthcare innovations. Roivant Sciences (ROIV) shares could be suitable for investors looking for opportunities in the biotechnology sector with a focus on innovation and research.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew Gline
Employees
721
Headquarters
London
Prihajajoči dogodki
Earnings
Upcoming earnings report